Back

Atrial fibrillation impairs dynamic right ventricular-pulmonary artery coupling and increases lung congestion during exercise in heart failure and preserved ejection fraction

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cutting-edge clinical investigations in heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Kazunori Omote

Hokkaido Cardiovascular Hospital, Sapporo (Japan)

4 More presentations in this session

Presentation thumbnail
Novel antisense therapy targeting microRNA-132 in patients with heart failure
Doctor J. Taubel (London, GB)
Abstract Slides Video
Presentation thumbnail
Cognitive impairment is a determinant of patient response to disease management programs to reduce readmission in heart failure
Doctor Q. Huynh (Hobart, AU)
Abstract Slides Video
Presentation thumbnail
Cardiovascular death risk in mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test
Doctor G. Gallo (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Deep learning for mortality prediction in patients with a de-novo or worsened heart failure
Doctor R. Herman (Aalst, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Cutting-edge clinical investigations in heart failure

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources